CRO · Private company
Fortrea
Track this companyFree. Adds Fortrea to your Dealase workspace and tells you when its record changes.
Clinical trials2314 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials23
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)PHASE2_PHASE3 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07219238 · fetched Nov 12, 2026
- A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395PHASE1 · RECRUITING · started Sep 25, 2026ClinicalTrials.gov NCT07820891 · fetched Nov 12, 2026
- Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinPHASE1 · COMPLETED · started Aug 6, 2026ClinicalTrials.gov NCT07754331 · fetched Nov 12, 2026
- Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 StudyPHASE3 · RECRUITING · started Apr 27, 2026ClinicalTrials.gov NCT07516132 · fetched Nov 12, 2026
- Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic LeukemiaPHASE1_PHASE2 · RECRUITING · started Nov 12, 2025ClinicalTrials.gov NCT07109219 · fetched Nov 12, 2026
- Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery OutcomesNA · RECRUITING · started Jul 16, 2025ClinicalTrials.gov NCT07017933 · fetched Nov 12, 2026
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaPHASE3 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06933472 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.PHASE1 · RECRUITING · started May 1, 2025ClinicalTrials.gov NCT06916806 · fetched Nov 12, 2026
- Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailurePHASE4 · RECRUITING · started Feb 4, 2025ClinicalTrials.gov NCT06651970 · fetched Nov 12, 2026
- A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 3, 2024ClinicalTrials.gov NCT06706817 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular DegenerationPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 27, 2024ClinicalTrials.gov NCT06495918 · fetched Nov 12, 2026
- A Study to Assess the Effect of AZD0780 on Ambulatory Blood PressurePHASE2 · COMPLETED · started Oct 30, 2024ClinicalTrials.gov NCT06692764 · fetched Nov 12, 2026
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 30, 2024ClinicalTrials.gov NCT06473779 · fetched Nov 12, 2026
- Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaPHASE4 · COMPLETED · started Sep 11, 2024ClinicalTrials.gov NCT06563102 · fetched Nov 12, 2026
- A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy VolunteersPHASE1 · COMPLETED · started Jul 2, 2024ClinicalTrials.gov NCT06398730 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 29, 2024ClinicalTrials.gov NCT06223958 · fetched Nov 12, 2026
- Pediatric Patients Aged 1 to 6 Years With APDSPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 30, 2023ClinicalTrials.gov NCT05693129 · fetched Nov 12, 2026
- Altropane Dose for Imaging Patients With Suspected Parkinson's DiseasePHASE2 · TERMINATED · started Apr 24, 2023ClinicalTrials.gov NCT05636852 · fetched Nov 12, 2026
- Pediatric Patients Aged 4 to 11 Years With APDSPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 1, 2023ClinicalTrials.gov NCT05438407 · fetched Nov 12, 2026
- Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell DiseasePHASE2 · COMPLETED · started Nov 18, 2021ClinicalTrials.gov NCT04817670 · fetched Nov 12, 2026
- Tailored vs. Anatomical Ablation Strategy for Persistent Atrial FibrillationNA · COMPLETED · started Feb 12, 2021ClinicalTrials.gov NCT04702451 · fetched Nov 12, 2026
- Adherus™ Dural Sealant in Spinal ProceduresNA · COMPLETED · started Nov 19, 2020ClinicalTrials.gov NCT04498026 · fetched Nov 12, 2026
- Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )PHASE3 · COMPLETED · started Dec 24, 2018ClinicalTrials.gov NCT03748134 · fetched Nov 12, 2026